APP and Alzheimer disease: Nevertheless, based on our experiments involving the overactivation of extrasynaptic NMDA receptors, we propose that the mislocalization of GluN2B-containing NMDA receptors, as observed in APP/PS1 mice, is a significant contributor to glutamatergic dysfunction which drives memory impairments in AD.